Most Read Articles
2 years ago
Catecholamines may regulate serum HDL cholesterol level, abdominal visceral and subcutaneous fat mass in men with pheochromocytoma, based on a cross-sectional and longitudinal follow-up study.
5 days ago
There is a growing number of targeted therapies being approved for use in cancer therapy in the home setting, and this poses a potential risk among family member and caregivers, particularly those of reproductive risk age, a recent study suggests.
2 years ago

Advanced endoscopic devices can significantly improve the detection rates of colorectal polyps and tumors beyond standard colonoscopy, which has a miss rate of about 25 percent, reported speakers at the “Inventor’s Corner” session of the conference.

Christina Lau, 3 years ago

In patients with metastatic breast cancer who failed to clear circulating tumor cells (CTCs) after one cycle of first-line chemotherapy, switching to a different chemotherapy does not improve survival or delay progression, the phase III SWOG S0500 trial has shown.    

Presepsin may help detect febrile neutropaenia during chemotherapy

4 months ago

Plasma presepsin appears to be an effective diagnostic marker for febrile neutropaenia (FN) in patients on massive chemotherapy, according to a Japanese study.

Derived from the cluster of differentiation 14 (CD14) protein, presepsin has been used for the prognosis and early diagnosis of severe sepsis. “While this molecule is a prompt and specific marker for bacterial infections, its reliability in FN is not yet confirmed,” said researchers, adding that the severe neutropaenia observed during massive chemotherapy may cause false-negative results for this marker.

To determine whether presepsin levels increase with bacteraemia in the setting of severe neutropaenia, researchers included patients with haematologic malignancy or bone marrow failure who developed severe neutropaenia after undergoing either conventional induction chemotherapy or haematopoietic stem cell transplantation (HSCT).

Patients were divided into two groups: those who were diagnosed with bacteraemia during a period of neutropaenia (FN group) and a control group consisting of patients with who had no febrile episodes for 3 weeks after chemotherapy but did not receive antimicrobial treatment (afebrile neutropaenia [AFN] group). A neutropaenic period was defined as a white blood cell (WBC) count <1,000/μL or neutrophil count <500/μL.

Plasma presepsin levels of FN patients were measured every 2 to 3 days and values compared with those of the AFN group. Outcome measures included presepsin levels at baseline and at FN onset, presepsin increase rate at FN onset, and onset/baseline ratio.

Eleven episodes of FN (with six gram-negative and five gram-positive pathogens identified in blood cultures) were reported and analysed in detail. Plasma presepsin levels were strongly associated with CRP levels (r=0.61; p<0.01), but not with the absolute WBC count (r=−0.19; p=0.19), absolute neutrophil count (r=−0.11; p=0.41) or absolute monocyte count (r=−0.12; p=0.40).

The presepsin cutoff value, which was set at 314 pg/mL, detected FN onset in nine of 11 cases, with the two undetected cases caused by Bacillus species.

On evaluating for renal function, researchers found no association between plasma presepsin levels and serum creatinine (r=0.08, p=0.55) or estimated glomerular filtration rate (r=0.21, p=0.12).

Although FN is a common infectious complication in chemotherapy, patients with haematologic malignancies who develop FN carry a higher risk of mortality.

In light of study findings, researchers posited that plasma presepsin may be a reliable marker of FN even in this population who has very low WBC counts. Closer monitoring of presepsin levels may be of benefit in the early diagnosis of FN, said researchers.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
2 years ago
Catecholamines may regulate serum HDL cholesterol level, abdominal visceral and subcutaneous fat mass in men with pheochromocytoma, based on a cross-sectional and longitudinal follow-up study.
5 days ago
There is a growing number of targeted therapies being approved for use in cancer therapy in the home setting, and this poses a potential risk among family member and caregivers, particularly those of reproductive risk age, a recent study suggests.
2 years ago

Advanced endoscopic devices can significantly improve the detection rates of colorectal polyps and tumors beyond standard colonoscopy, which has a miss rate of about 25 percent, reported speakers at the “Inventor’s Corner” session of the conference.

Christina Lau, 3 years ago

In patients with metastatic breast cancer who failed to clear circulating tumor cells (CTCs) after one cycle of first-line chemotherapy, switching to a different chemotherapy does not improve survival or delay progression, the phase III SWOG S0500 trial has shown.